Similarly, in breast cancers, it was also found that MET mutation or amplification promotes tumor metastasis into more diverse organs; the median number of organs involved for the group of tumors with non-amplified MET was 2, compared to 7 for the MET amplified group. Here, MET is linked to breast carcinoma.